FDA clears Labopharm’s antidepressant
February 3, 2010 by leonardzehr · Leave a Comment
The FDA has approved Labopharm’s Oleptro extended release tablets, a once-daily formulation of the antidepressant trazodone, to treat major depressive disorder in adults. “Oleptro represents Labopharm’s second Contramid technology-based product to receive FDA approval in just over a year,” CEO James Howard-Tripp said in a statement, adding that the company (TSX:DDS; NASDAQ:DDSS) is preparing the [...]
Listen to BioTuesdays 
